cisplatin
Selected indexed studies
- Cisplatin. (Cancer Chemother Biol Response Modif, 1992) [PMID:1389927]
- Cisplatin-based combination therapies: Their efficacy with a focus on ginsenosides co-administration. (Pharmacol Res, 2024) [PMID:38582357]
- Immunomodulatory effects and improved outcomes with cisplatin- versus carboplatin-based chemotherapy plus atezolizumab in urothelial cancer. (Cell Rep Med, 2024) [PMID:38280376]
_Worker-drafted node — pending editorial review._
Connections
cisplatin is a side effect of
Sources
- Cisplatin. (1992) pubmed
- Cisplatin-based combination therapies: Their efficacy with a focus on ginsenosides co-administration. (2024) pubmed
- Immunomodulatory effects and improved outcomes with cisplatin- versus carboplatin-based chemotherapy plus atezolizumab in urothelial cancer. (2024) pubmed
- Cisplatin Chemotherapy and Cochlear Damage: Otoprotective and Chemosensitization Properties of Polyphenols. (2022) pubmed
- Management of cisplatin-associated toxicities in bladder cancer patients. (2020) pubmed
- Effects of natural products on cisplatin ototoxicity and chemotherapeutic efficacy. (2023) pubmed
- The latest advances of cisplatin liposomal formulations: essentials for preparation and analysis. (2020) pubmed
- [50th anniversary of cisplatin]. (2017) pubmed
- Cisplatin induced arrhythmia; electrolyte imbalance or disturbance of the SA node? (2017) pubmed
- Easing cisplatin's toll in nasopharyngeal carcinoma. (2025) pubmed